Global Venous thromboembolism(VTE)Therapeutics Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 8922

Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual (Heit, 2015). In VTE, a DVT is a clot that occurs only in the veins; generally, they occur in the deep veins of the legs and pelvis, but may also occur in the veins of the upper body (AHA, 2017; Cohen et al., 2007; Heit, 2015). The clot may break off from its original location and travel throughout the circulatory system, and if the clot ends up in the lung, it is known as a PE 
One of the Major drivers of VTE market growth over the forecast period is the increase in patient shares towards the NOACs due to increased confidence among physicians about using these novel therapies.

The global Venous thromboembolism(VTE)Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Venous thromboembolism(VTE)Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Venous thromboembolism(VTE)Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Boehringer Ingelheim
Bayer
Janssen
Bristol-Myers Squibb
Pfizer
Daiichi-Sankyo
Portola Pharmaceuticals
Armetheon

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Deep Vein Thrombosis(DVT)
Pulmonary Embolism(PE)
Others

Segment by Application
Hospital
ASCs
Research Institutes

Table of Contents

Executive Summary
1 Venous thromboembolism(VTE)Therapeutics Market Overview
1.1 Product Overview and Scope of Venous thromboembolism(VTE)Therapeutics
1.2 Venous thromboembolism(VTE)Therapeutics Segment by Type
1.2.1 Global Venous thromboembolism(VTE)Therapeutics Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Deep Vein Thrombosis(DVT)
1.2.3 Pulmonary Embolism(PE)
1.2.4 Others
1.3 Venous thromboembolism(VTE)Therapeutics Segment by Application
1.3.1 Venous thromboembolism(VTE)Therapeutics Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 ASCs
1.3.4 Research Institutes
1.4 Global Venous thromboembolism(VTE)Therapeutics Market by Region
1.4.1 Global Venous thromboembolism(VTE)Therapeutics Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Venous thromboembolism(VTE)Therapeutics Market Size
1.5.1 Global Venous thromboembolism(VTE)Therapeutics Revenue (2014-2025)
1.5.2 Global Venous thromboembolism(VTE)Therapeutics Production (2014-2025)

2 Global Venous thromboembolism(VTE)Therapeutics Market Competition by Manufacturers
2.1 Global Venous thromboembolism(VTE)Therapeutics Production Market Share by Manufacturers (2014-2019)
2.2 Global Venous thromboembolism(VTE)Therapeutics Revenue Share by Manufacturers (2014-2019)
2.3 Global Venous thromboembolism(VTE)Therapeutics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Venous thromboembolism(VTE)Therapeutics Production Sites, Area Served, Product Types
2.5 Venous thromboembolism(VTE)Therapeutics Market Competitive Situation and Trends
2.5.1 Venous thromboembolism(VTE)Therapeutics Market Concentration Rate
2.5.2 Venous thromboembolism(VTE)Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Venous thromboembolism(VTE)Therapeutics Production Market Share by Regions
3.1 Global Venous thromboembolism(VTE)Therapeutics Production Market Share by Regions
3.2 Global Venous thromboembolism(VTE)Therapeutics Revenue Market Share by Regions (2014-2019)
3.3 Global Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Venous thromboembolism(VTE)Therapeutics Production
3.4.1 North America Venous thromboembolism(VTE)Therapeutics Production Growth Rate (2014-2019)
3.4.2 North America Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Venous thromboembolism(VTE)Therapeutics Production
3.5.1 Europe Venous thromboembolism(VTE)Therapeutics Production Growth Rate (2014-2019)
3.5.2 Europe Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Venous thromboembolism(VTE)Therapeutics Production (2014-2019)
3.6.1 China Venous thromboembolism(VTE)Therapeutics Production Growth Rate (2014-2019)
3.6.2 China Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Venous thromboembolism(VTE)Therapeutics Production (2014-2019)
3.7.1 Japan Venous thromboembolism(VTE)Therapeutics Production Growth Rate (2014-2019)
3.7.2 Japan Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Venous thromboembolism(VTE)Therapeutics Consumption by Regions
4.1 Global Venous thromboembolism(VTE)Therapeutics Consumption by Regions
4.2 North America Venous thromboembolism(VTE)Therapeutics Consumption (2014-2019)
4.3 Europe Venous thromboembolism(VTE)Therapeutics Consumption (2014-2019)
4.4 China Venous thromboembolism(VTE)Therapeutics Consumption (2014-2019)
4.5 Japan Venous thromboembolism(VTE)Therapeutics Consumption (2014-2019)

5 Global Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price Trend by Type
5.1 Global Venous thromboembolism(VTE)Therapeutics Production Market Share by Type (2014-2019)
5.2 Global Venous thromboembolism(VTE)Therapeutics Revenue Market Share by Type (2014-2019)
5.3 Global Venous thromboembolism(VTE)Therapeutics Price by Type (2014-2019)
5.4 Global Venous thromboembolism(VTE)Therapeutics Production Growth by Type (2014-2019)

6 Global Venous thromboembolism(VTE)Therapeutics Market Analysis by Applications
6.1 Global Venous thromboembolism(VTE)Therapeutics Consumption Market Share by Application (2014-2019)
6.2 Global Venous thromboembolism(VTE)Therapeutics Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Venous thromboembolism(VTE)Therapeutics Business
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Venous thromboembolism(VTE)Therapeutics Production Sites and Area Served
7.1.2 Venous thromboembolism(VTE)Therapeutics Product Introduction, Application and Specification
7.1.3 Boehringer Ingelheim Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Bayer
7.2.1 Bayer Venous thromboembolism(VTE)Therapeutics Production Sites and Area Served
7.2.2 Venous thromboembolism(VTE)Therapeutics Product Introduction, Application and Specification
7.2.3 Bayer Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Janssen
7.3.1 Janssen Venous thromboembolism(VTE)Therapeutics Production Sites and Area Served
7.3.2 Venous thromboembolism(VTE)Therapeutics Product Introduction, Application and Specification
7.3.3 Janssen Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Venous thromboembolism(VTE)Therapeutics Production Sites and Area Served
7.4.2 Venous thromboembolism(VTE)Therapeutics Product Introduction, Application and Specification
7.4.3 Bristol-Myers Squibb Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Pfizer
7.5.1 Pfizer Venous thromboembolism(VTE)Therapeutics Production Sites and Area Served
7.5.2 Venous thromboembolism(VTE)Therapeutics Product Introduction, Application and Specification
7.5.3 Pfizer Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Daiichi-Sankyo
7.6.1 Daiichi-Sankyo Venous thromboembolism(VTE)Therapeutics Production Sites and Area Served
7.6.2 Venous thromboembolism(VTE)Therapeutics Product Introduction, Application and Specification
7.6.3 Daiichi-Sankyo Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Portola Pharmaceuticals
7.7.1 Portola Pharmaceuticals Venous thromboembolism(VTE)Therapeutics Production Sites and Area Served
7.7.2 Venous thromboembolism(VTE)Therapeutics Product Introduction, Application and Specification
7.7.3 Portola Pharmaceuticals Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Armetheon
7.8.1 Armetheon Venous thromboembolism(VTE)Therapeutics Production Sites and Area Served
7.8.2 Venous thromboembolism(VTE)Therapeutics Product Introduction, Application and Specification
7.8.3 Armetheon Venous thromboembolism(VTE)Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served

8 Venous thromboembolism(VTE)Therapeutics Manufacturing Cost Analysis
8.1 Venous thromboembolism(VTE)Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Venous thromboembolism(VTE)Therapeutics
8.4 Venous thromboembolism(VTE)Therapeutics Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Venous thromboembolism(VTE)Therapeutics Distributors List
9.3 Venous thromboembolism(VTE)Therapeutics Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Venous thromboembolism(VTE)Therapeutics Market Forecast
11.1 Global Venous thromboembolism(VTE)Therapeutics Production, Revenue Forecast
11.1.1 Global Venous thromboembolism(VTE)Therapeutics Production Growth Rate Forecast (2019-2025)
11.1.2 Global Venous thromboembolism(VTE)Therapeutics Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Venous thromboembolism(VTE)Therapeutics Price and Trend Forecast (2019-2025)
11.2 Global Venous thromboembolism(VTE)Therapeutics Production Forecast by Regions (2019-2025)
11.2.1 North America Venous thromboembolism(VTE)Therapeutics Production, Revenue Forecast (2019-2025)
11.2.2 Europe Venous thromboembolism(VTE)Therapeutics Production, Revenue Forecast (2019-2025)
11.2.3 China Venous thromboembolism(VTE)Therapeutics Production, Revenue Forecast (2019-2025)
11.2.4 Japan Venous thromboembolism(VTE)Therapeutics Production, Revenue Forecast (2019-2025)
11.3 Global Venous thromboembolism(VTE)Therapeutics Consumption Forecast by Regions (2019-2025)
11.3.1 North America Venous thromboembolism(VTE)Therapeutics Consumption Forecast (2019-2025)
11.3.2 Europe Venous thromboembolism(VTE)Therapeutics Consumption Forecast (2019-2025)
11.3.3 China Venous thromboembolism(VTE)Therapeutics Consumption Forecast (2019-2025)
11.3.4 Japan Venous thromboembolism(VTE)Therapeutics Consumption Forecast (2019-2025)
11.4 Global Venous thromboembolism(VTE)Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Venous thromboembolism(VTE)Therapeutics Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer